Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Diabetologia|March 12, 2026
Impact of canagliflozin on the cardiorenal effects of dietary sodium intake in type 2 diabetes: a post hoc analysis of the CREDENCE trialMartina Chiriacò, Domenico Tricò, Alberto Giannoni, et al.
Diabetes, Obesity & Metabolism|April 1, 2026
Exercise Metabolic Flexibility in Type 2 Diabetes Treated With Empagliflozin: An Exploratory Analysis of the Randomised Trial EMPA-HEARTLorenzo Nesti, Lorenza Santoni, Simona Baldi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 4, 2020
Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: a prognosis studyNicola R Pugliese, Iacopo Fabiani, Lorenzo Conte, et al.
Cardiovascular Diabetology|September 12, 2022
Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trialLorenzo Nesti, Nicola Riccardo Pugliese, Paolo Sciuto, et al.
Diabetologia|November 3, 2019
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysisDomenico Tricò, Alessandro Mengozzi, Lorenzo Nesti, et al.
Cardiovascular Diabetology|February 24, 2026
SGLT2 inhibitors reduce the salt sensitivity of blood pressure in type 2 diabetes via enhanced postprandial natriuresisMartina Chiriacò, Domenico Tricò, Luca Sacchetta, et al.
The Journal of Clinical Endocrinology and Metabolism|August 31, 2023
At any Level of Adiposity, Relatively Elevated Leptin Concentrations Are Associated With Decreased Insulin SensitivityMartina Chiriacò, Lorenzo Nesti, Allan Flyvbjerg, et al.
Diabetologia|November 16, 2023
Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trialDomenico Tricò, Maria Chiara Masoni, Simona Baldi, et al.
Heart Rhythm|September 19, 2025
Impact of empagliflozin and dapagliflozin on sudden cardiac death: A systematic review and meta-analysis of adjudicated randomized evidenceAndrea Matteucci, Claudio Pandozi, Michela Bonanni, et al.
Diabetes, Obesity & Metabolism|October 13, 2023
Distinct effects of type 2 diabetes and obesity on cardiopulmonary performanceLorenzo Nesti, Nicola Riccardo Pugliese, Lorenza Santoni, et al.
Pageof 5